From product development to translation into clinical trials, GTx’s clinically validated scalable electroporation technology is equipped to handle your most complex cellular engineering demands.
- Rapidly transfect from 75 thousand to 20 billion cells
- Move forward with 21 CFR Part 11 enabled software
- Develop quickly with an established regulatory path supported by a FDA Master File
- Manufacture confidently with closed, cGMP-compliant, ISO-certified and CE-marked products
- Enjoy MaxCyte’s proprietary Flow Electroporation?sup> technology